|
|
- Tom Laughren, M.D., Director, Division of Psychiatry Products, FDA, Commentary on Centralized Ratings at NCDEU 2008
- MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures
-
April 2007 Dr Scott Gottlieb, the recently
resigned Deputy Commissioner of the FDA, is elected to the MedAvante Board
of Directors
- May 2007 Dr. Earl Giller,
MedAvante Senior Scientific Advisor and Vice President of Clinical
Development, Marinus Pharmaceuticals will present, "Is There a Way to Stop
Clinical Trials Failing and Could Centralized Ratings of Symptoms Be a
Solution?" at the Global CNS Drugs Summit, May 30-31, 2007, Hilton City
Avenue, Philadelphia, PA. Visit the MedAvante exhibit space at the
conference both days. To register for the meeting or obtain further
information, log on to:
http://www.eyeforpharma.com/cns2007
- June 2006 MedAvante in the News—US1 Article
- September 2005 Ronald Saldarini PhD named as Chairman of the Board of MedAvante Inc.
|
 |
|
